Literature DB >> 11738231

Ophidian envenomation strategies and the role of purines.

Steven D Aird1.   

Abstract

Snake envenomation employs three well integrated strategies: prey immobilization via hypotension, prey immobilization via paralysis, and prey digestion. Purines (adenosine, guanosine and inosine) evidently play a central role in the envenomation strategies of most advanced snakes. Purines constitute the perfect multifunctional toxins, participating simultaneously in all three envenomation strategies. Because they are endogenous regulatory compounds in all vertebrates, it is impossible for any prey organism to develop resistance to them. Purine generation from endogenous precursors in the prey explains the presence of many hitherto unexplained enzyme activities in snake venoms: 5'-nucleotidase, endonucleases (including ribonuclease), phosphodiesterase, ATPase, ADPase, phosphomonoesterase, and NADase. Phospholipases A(2), cytotoxins, myotoxins, and heparinase also participate in purine liberation, in addition to their better known functions. Adenosine contributes to prey immobilization by activation of neuronal adenosine A(1) receptors, suppressing acetylcholine release from motor neurons and excitatory neurotransmitters from central sites. It also exacerbates venom-induced hypotension by activating A(2) receptors in the vasculature. Adenosine and inosine both activate mast cell A(3) receptors, liberating vasoactive substances and increasing vascular permeability. Guanosine probably contributes to hypotension, by augmenting vascular endothelial cGMP levels via an unknown mechanism. Novel functions are suggested for toxins that act upon blood coagulation factors, including nitric oxide production, using the prey's carboxypeptidases. Leucine aminopeptidase may link venom hemorrhagic metalloproteases and endogenous chymotrypsin-like proteases with venom L-amino acid oxidase (LAO), accelerating the latter. The primary function of LAO is probably to promote prey hypotension by activating soluble guanylate cyclase in the presence of superoxide dismutase. LAO's apoptotic activity, too slow to be relevant to prey capture, is undoubtedly secondary and probably serves principally a digestive function. It is concluded that the principal function of L-type Ca(2+) channel antagonists and muscarinic toxins, in Dendroaspis venoms, and acetylcholinesterase in other elapid venoms, is to promote hypotension. Venom dipeptidyl peptidase IV-like enzymes probably also contribute to hypotension by destroying vasoconstrictive peptides such as Peptide YY, neuropeptide Y and substance P. Purines apparently bind to other toxins which then serve as molecular chaperones to deposit the bound purines at specific subsets of purine receptors. The assignment of pharmacological activities such as transient neurotransmitter suppression, histamine release and antinociception, to a variety of proteinaceous toxins, is probably erroneous. Such effects are probably due instead to purines bound to these toxins, and/or to free venom purines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11738231     DOI: 10.1016/s0041-0101(01)00232-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  71 in total

Review 1.  Venom effects on monoaminergic systems.

Authors:  Aviva Weisel-Eichler; Frederic Libersat
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2004-05-25       Impact factor: 1.836

2.  Antibodies against Venom of the Snake Deinagkistrodon acutus.

Authors:  Chi-Hsin Lee; Yu-Ching Lee; Meng-Huei Liang; Sy-Jye Leu; Liang-Tzung Lin; Jen-Ron Chiang; Yi-Yuan Yang
Journal:  Appl Environ Microbiol       Date:  2015-10-16       Impact factor: 4.792

3.  A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome.

Authors:  Ana B G Veiga; José M C Ribeiro; Jorge A Guimarães; Ivo M B Francischetti
Journal:  Gene       Date:  2005-08-01       Impact factor: 3.688

4.  Homology modeling, molecular dynamics and atomic level interaction study of snake venom 5' nucleotidase.

Authors:  A Syed Yasir Arafat; A Arun; M Ilamathi; J Asha; P R Sivashankari; Cletus J M D'Souza; V Sivaramakrishnan; B L Dhananjaya
Journal:  J Mol Model       Date:  2014-02-25       Impact factor: 1.810

5.  Clawing through evolution: toxin diversification and convergence in the ancient lineage Chilopoda (centipedes).

Authors:  Eivind A B Undheim; Alun Jones; Karl R Clauser; John W Holland; Sandy S Pineda; Glenn F King; Bryan G Fry
Journal:  Mol Biol Evol       Date:  2014-05-20       Impact factor: 16.240

6.  A lipidomics approach reveals new insights into Crotalus durissus terrificus and Bothrops moojeni snake venoms.

Authors:  Tanize Acunha; Viviani Nardini; Lúcia Helena Faccioli
Journal:  Arch Toxicol       Date:  2020-09-03       Impact factor: 5.153

7.  Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Authors:  Steven D Aird; Nelson Jorge da Silva; Lijun Qiu; Alejandro Villar-Briones; Vera Aparecida Saddi; Mariana Pires de Campos Telles; Miguel L Grau; Alexander S Mikheyev
Journal:  Toxins (Basel)       Date:  2017-06-08       Impact factor: 4.546

8.  Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins.

Authors:  Ivo M B Francischetti; Van My-Pham; Jim Harrison; Mark K Garfield; José M C Ribeiro
Journal:  Gene       Date:  2004-08-04       Impact factor: 3.688

9.  Complementary DNA sequencing and identification of mRNAs from the venomous gland of Agkistrodon piscivorus leucostoma.

Authors:  Ying Jia; Bruno A Cantu; Elda E Sánchez; John C Pérez
Journal:  Toxicon       Date:  2008-04-03       Impact factor: 3.033

10.  Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts.

Authors:  Nicholas R Casewell; Robert A Harrison; Wolfgang Wüster; Simon C Wagstaff
Journal:  BMC Genomics       Date:  2009-11-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.